Evidence map›Paper›PMID 40271600›Full record

ReviewMaterials (Basel, Switzerland)2025

Meta-Analysis of Materials and Treatments Used in Contact Lenses: Implications for Lens Characteristics.

Ana Paula Oliveira, Clara Martinez-Perez

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ana Paula OliveiraInstituto Superior de Educação e Ciências de Lisboa (ISEC Lisboa), Alameda das Linhas de Torres, 179, 1750-142 Lisboa, Portugal.ORCID 0000-0003-0152-8141
Clara Martinez-PerezInstituto Superior de Educação e Ciências de Lisboa (ISEC Lisboa), Alameda das Linhas de Torres, 179, 1750-142 Lisboa, Portugal.ORCID 0000-0002-0996-5007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A meta-analysis was conducted to assess the evolution of, applications of, and recent advancements in materials and surface treatments for contact lenses. This study aimed to comprehensively synthesize the available data, focusing on innovations that enhance vision correction, comfort, and safety while emphasizing sustainability as a critical factor in future development. Registered with PROSPERO, this analysis adhered to the PRISMA and AMSTAR-2 guidelines. A systematic review of databases including PubMed, Web of Science, and Scopus was performed for studies published between 2019 and 2024, without language restrictions. Observational studies on optical materials and lens treatments were included, and a random-effects model was used to address the high heterogeneity among the included studies. From the nine studies that were analyzed, significant advancements were identified regarding the functional properties of materials and treatments. Key advancements included technologies like self-lubricating lenses that reduce friction, nanogels for prolonged therapeutic drug delivery, and coatings that minimize protein and lipid deposition, ensuring greater comfort and extended wearability. Additionally, innovations in biodegradable and eco-friendly materials underscore the industry's commitment to reducing the environmental impact of contact lenses, addressing challenges related to lens disposal and recycling. These advancements highlight the potential of integrating functional improvements with sustainability, paving the way for more effective and environmentally responsible contact lenses.

Indexed as

contact lenseslens characteristicslens coatingsoptical materialsoxygen permeability

Identifiers

PMID40271600
PMCPMC11989920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.